Apollo Medical (AMEH) Stock Price, News & Analysis

Company Overview

Apollo Medical Holdings, Inc., a physician-centric technology-powered healthcare company, provides medical care services in the United States. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients in California. The company was incorporated in 1985 and is headquartered in Alhambra, California.

Key Stats

• Today's Range: $40.71 to $42.75
• 50-Day Range: $35.30 to $41.70
• 52-Week Range: $28.86 to $43.12
• Volume: 313,900 shs
• Average Volume: 166,711 shs
• Market Capitalization: $2.38 billion
• P/E Ratio: 40.82
• Dividend Yield: N/A
• Price Target: $47.75
• Consensus Rating: Moderate Buy

Apollo Medical Stock Analysis - MarketRank™

Apollo Medical scored higher than 60% of companies evaluated by MarketBeat, and ranked 446th out of 953 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.4 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Apollo Medical has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 3 buy ratings, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

Apollo Medical has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 3.1 / 5
• Proj. Earnings Growth: 32.50%

Earnings Growth

Earnings for Apollo Medical are expected to grow by 32.50% in the coming year, from $1.20 to $1.59 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Apollo Medical is 40.82, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 125.81.

Price to Earnings Ratio vs. Sector

The P/E ratio of Apollo Medical is 40.82, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 105.04.

Price to Earnings Growth Ratio

Apollo Medical has a PEG Ratio of 1.15. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Apollo Medical has a P/B Ratio of 4.25. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for AMEH.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Apollo Medical does not currently pay a dividend.

Dividend Growth

Apollo Medical does not have a long track record of dividend growth.

Sustainability and ESG

• Score: 4.3 / 5
• Environmental Score: -0.69

Short Interest

There is no current short interest data available for AMEH.

News and Social Media

• Score: N/A
• News Sentiment: N/A

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Apollo Medical insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 8.46% of the stock of Apollo Medical is held by insiders.

Percentage Held by Institutions

Only 35.88% of the stock of Apollo Medical is held by institutions.

AMEH Stock Analysis - Frequently Asked Questions

How were Apollo Medical's earnings last quarter?

Apollo Medical Holdings, Inc. (NASDAQ:AMEH) issued its earnings results on Thursday, November, 4th. The company reported $0.69 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.34 by $0.35. The firm earned $227.12 million during the quarter. Apollo Medical had a net margin of 3.56% and a trailing twelve-month return on equity of 9.90%.

Does Apollo Medical have any subsidiaries?

Apollo Medical subsidiaries include Standard Aero (alliance) Inc..

What other stocks do shareholders of Apollo Medical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Apollo Medical investors own include Meta Platforms (META), NVIDIA (NVDA), Broadcom (AVGO), Advanced Micro Devices (AMD), CrowdStrike (CRWD), General Electric (GE) and ServiceNow (NOW).

Company Calendar

• Last Earnings: 11/04/2021
• Today: 11/22/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Management consulting services
• Sub-Industry: N/A
• Current Symbol: NASDAQ:AMEH
• CUSIP: N/A
• CIK: 1083446
• Web: www.apollomed.net
• Phone: (626) 282-0288
• Fax: 818-839-5190
• Employees: 1,362
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $47.75
• High Stock Price Target: $55.00
• Low Stock Price Target: $41.00
• Potential Upside/Downside: +17.0%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.75
• Research Coverage: 4 Analysts

Profitability

• EPS (Most Recent Fiscal Year): $1.00
• Trailing P/E Ratio: 40.82
• Forward P/E Ratio: 34.02
• P/E Growth: 1.15
• Net Income: $45.17 million
• Net Margins: 3.56%
• Pretax Margin: 7.48%
• Return on Equity: 9.90%
• Return on Assets: 5.51%

Debt

• Debt-to-Equity Ratio: 0.35
• Current Ratio: 2.35
• Quick Ratio: 2.35

Sales & Book Value

• Annual Sales: $1.14 billion
• Price / Sales: 2.08
• Cash Flow: $1.26 per share
• Price / Cash Flow: 32.51
• Book Value: $9.60 per share
• Price / Book: 4.25

Miscellaneous

• Outstanding Shares: 58,280,000
• Free Float: 53,353,000
• Market Cap: $2.38 billion
• Optionable: Optionable
• Beta: 1.04